Central role of Snail1 in the regulation of EMT and resistance in cancer: A target for therapeutic intervention

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Kaufhold, Samantha ^a   Bonavida, Benjamin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; EMT; Metastasis; Resistance; Snail; Stem cells

Indexed keywords

CLAUDIN; CYTOKERATIN 18; FIBRONECTIN; GELATINASE A; GELATINASE B; LYMPHOID ENHANCER FACTOR 1; MUCIN 1; OCCLUDIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SNAIL1; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

BLADDER CARCINOMA; BREAST CARCINOMA; CANCER RESISTANCE; CANCER STEM CELL; CHEMOSENSITIVITY; COLORECTAL CARCINOMA; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IMMUNITY; LIVER CELL CARCINOMA; MELANOMA; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; OVARY CARCINOMA; PANCREAS CARCINOMA; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; STOMACH CARCINOMA; SYNOVIAL SARCOMA; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; UTERINE CERVIX CARCINOMA; AMINO ACID SEQUENCE; ANIMAL; GENETICS; METABOLISM; MOLECULAR GENETICS; NEOPLASM; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS;

EID: 84906978992     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-014-0062-0     Document Type: Review

References (187)

1. The snail superfamily of zinc-finger transcription factors. MA Nieto, Nat Rev Mol Cell Biol 2002 3 155 166 11994736
2. The Drosophila developmental gene snail encodes a protein with nucleic acid binding fingers. J Boulay, C Dennefeld, A Alberga, Nature 1987 330 395 398 3683556
3. The increasing complexity of the snail gene superfamily in metazoan evolution. M Manzanares, A Locascio, MA Nieto, Trends Genet 2001 17 178 181 11275308
4. Mutations and chromosomal rearrangements affecting the expression of snail, a gene involved in embryonic patterning in Drosophila melanogaster. Y Grau, C Carteret, P Simpson, Genetics 1984 108 347 360 17246230
5. Mutations affecting the pattern of the larval cuticle in Drosophila melanogaster. I. Zygotic loci on the second chromosome. C Nusslein-Volhard, E Weischaus, H Kluding, Wilheim Roux's Arch Dev Biol 1984 193 267 282
6. Characterization of the human snail (SNAI1) gene and exclusion as a major disease gene in craniosynostosis. S Twigg, AOM Wilkie, Hum Genet 1999 105 320 326 10543399
7. Genomic organization, expression, and chromosome location of the human snail gene (SNAI1) and a related processed pseudogene (SNAI1P). W Paznekas, K Okajima, M Schertzer, S Wood, E Jabs, Genomics 1999 62 42 49 10585766
8. Evolutionary history of the snail/scratch superfamily. A Barrallo-Gimeno, MA Nieto, Trends Genet 2009 25 248 252 19427053
9. http://www.uniprot.org/uniprot/O95863 Human Snail1: sequence retrieved from and alignments run through NIH BLAST http://blast.st-va.ncbi.nlm.nih.gov/Blast.cgi.
10. The basics of epithelial-mesenchymal transition. R Kalluri, R Weinberg, J Clin Invest 2009 119 1420 1428 19487818
11. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. EA Carver, R Jiang, T Gridley, Mol Cell Biol 2001 21 8184 8188 11689706
12. The Snail genes as inducers of cell movement and survival: implications in development and cancer. A Barrallo-Gimeno, MA Nieto, Development 2005 132 3151 3161 15983400
13. Aberrant expression of the transcription factors Snail and Slug alters the response to genotoxic stress. M Kajita, K McClinic, P Wade, Mol Cell Biol 2004 24 7559 7566 15314165
14. The epithelial-mesenchymal transition generates cells with properties of stem cells. S Mani, W Guo, MJ Liao, E Eaton, A Ayyanan, AY Zhou, M Brooks, F Reinhard, CC Zhang, M Shipitsin, LL Campbell, K Polyak, C Brisken, J Yang, RA Weinberg, Cell 2008 133 704 715 18485877
15. Snail contributes to the maintenance of stem cell-like phenotype cells in human pancreatic cancer. W Zhou, R Lv, W Qi, D Wu, Y Xu, W Liu, Y Mou, L Wang, PLoS One 2014 9 87409 24489910
16. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway. H Wang, G Zhang, H Zhang, F Zhang, BP Zhou, F Ning, HS Wang, SH Cai, J Du, Eur J Pharmacol 2014 723 156 166 24333218
17. Hypoxia-inducible factors and the response to hypoxic stress. AJ Majmundar, WJ Wong, MC Simon, Mol Cell 2010 40 294 309 20965423
18. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. H Peinado, M Del Carmen Iglesias-de la Cruz, D Olmeda, K Csiszar, KS Fong, S Vega, MA Nieto, A Cano, F Portillo, EMBO J 2005 24 3446 3458 16096638
19. Hypoxia-induced snail expression through transcriptional regulation by HIF-1alpha in pancreatic cancer cells. GH Zhu, C Huang, ZZ Feng, XH Lv, ZJ Qiu, Dig Dis Sci 2013 58 3503 3515 23979441
20. Regulation of snail transcription during epithelial to mesenchymal transition of tumor cells. MJ Barbera, I Puig, D Dominguez, S Julien-Grille, S Guaita-Esteruelas, S Peiro, J Baulida, C Franci, S Dedhar, L Larue, A Garcia de Herreros, Oncogene 2004 23 7345 7354 15286702
21. IKKalpha controls canonical TGFBeta-SMAD signaling to regulate genes expressing snail and slug during EMT in Panc1 cells. M Brandl, B Seidler, F Haller, J Adamski, RM Schmid, D Saur, G Schneider, J Cell Sci 2010 123 4231 4239 21081648
22. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. S Thuault, EJ Tan, H Peinado, A Cano, CH Heldin, A Moustakas, J Biol Chem 2008 283 33437 33446 18832382
23. Integrin-linked kinase regulates E-Cadherin expression through PARP-1. T McPhee, P McDonald, A Oloumi, S Dedhar, Dev Dyn 2008 237 2737 2747 18773488
24. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. A Yadav, B Kumar, J Datta, T Teknos, P Kumar, Mol Cancer Res 2011 9 1658 1667 21976712
25. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) induction on Snail expression during mouse decidualization. XH Zhang, X Liang, TS Wang, XH Liang, RJ Zuo, WB Deng, ZR Zhang, FN Qin, ZA Zhao, ZM Yang, Mol Cell Endocrinol 2013 381 272 279 23994020
26. Gli1 acts through Snail and E-Cadherin to promote nuclear signaling by Beta-catenin. X Li, W Deng, S Lobo-Ruppert, J Ruppert, Oncogene 2007 26 4489 4498 17297467
27. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. N Fujita, D Jaye, M Kajita, C Geigerman, C Moreno, P Wade, Cell 2003 113 207 219 12705869
28. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. A Dhasarathy, M Kajita, P Wade, Mol Endocrinol 2007 21 2907 2918 17761946
29. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. S Grotegut, D von Schweinitz, G Christofori, F Lehembre, EMBO J 2006 25 3534 3545 16858414
30. Yin Yang 1 regulates the expression of Snail through a distal enhancer. M Palmer, P Majumder, J Cooper, H Yoon, P Wade, J Boss, Mol Cancer Res 2009 7 221 229 19208738
31. Snail1 transcriptional repressor binds to its own promoter and controls its expression. S Peiro, M Escriva, I Puig, MJ Barbera, N Dave, N Herranz, MJ Larriba, M Takkunen, C Franci, A Munoz, I Virtanen, J Baulida, A Garcia de herreros, Nucleic Acids Res 2006 34 2077 2084 16617148
32. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesencymal transition. NH Kim, HS Kim, XY Li, I Lee, HS Choi, SE Kang, SY Cha, JK Ryu, D Yoon, ER Fearon, RG Rowe, S Lee, CA Maher, SJ Weiss, JI Yook, J Cell Biol 2011 195 417 433 22024162
33. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. BP Zhou, J Deng, W Xia, J Xu, Y Li, M Gunduz, MC Hung, Nat Cell Biol 2004 6 931 940 15448698
34. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. M Katoh, M Katoh, Cancer Biol Ther 2006 5 1059 1064 16940750
35. The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. R Vinas-Castells, M Beltran, G Valls, I Gomez, JM Garcia, B Montserrat-Sentis, J Baulida, F Bonilla, A Garcia de herreros, VM Diaz, J Biol Chem 2010 285 3794 3805 19955572
36. Pak1 phosphorylation of snail, a master regulator of epithelial-to-mesenchhyme transition, modulates snail's subcellular localization and functions. Z Yang, S Rayala, D Nguyen, R Vadlmudi, S Chen, R Kumar, Cancer Res 2005 65 3179 3184 15833848
37. Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor. D Dominguez, B Montserrat-Sentis, A Virgos-Soler, S Guaita, J Grueso, M Porta, I Puig, J Baulida, C Franci, A Garcia de Herreros, Mol Cell Biol 2003 23 5078 5089 12832491
38. Nuclear localization signals of the E-Cadherin transcriptional repressor Snail. H Ko, H Kim, N Kim, S Lee, K Kim, S Hong, J Yook, Cells Tissues Organs 2007 185 66 72 17587810
39. Stabilization of snail by NFkappaB is required for inflammation-induced cell migration and invasion. Y Wu, J Deng, PG Rychahou, S Qiu, BM Evers, BP Zhou, Cancer Cell 2009 15 416 428 19411070
40. Snail: more than EMT. Y Wu, BP Zhou, Cell Adhes Migrat 2010 4 199 203
41. Wnt-dependent regulation of the E-cadherin repressor snail. JI Yook, XY Li, I Ota, ER Fearon, SJ Weiss, J Biol Chem 2005 280 11740 11748 15647282
42. Zhang JP, Zeng C, Xu L, Gong J, Fang JH, Zhuang SM: MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Oncogene 2013, Epub ahead of print.
43. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. M Tsubaki, M Komai, SI Fujimoto, T Itoh, M Imano, K Sakamoto, H Shimaoka, T Takeda, N Ogawa, K Mashimo, D Fujiwara, J Mukai, K Sakaguchi, T Satou, S Nishida, J Exp Clin Cancer Res 2013 32 62 24011086
44. Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. S Julien, I Puig, E Caretti, J Bonaventure, L Nelles, F van Roy, C Dargemont, AG de Herreros, A Bellacosa, L Larue, Oncogene 2007 26 7445 7456 17563753
45. TGF-Beta1 inhibits trophoblast cell invasion by inducing snail-mediated down-regulation of ve-cadherin. JC Cheng, HM Chang, P Leung, J Biol Chem 2013 288 33181 33192 24106276
46. Role of Ras signaling in the induction of snail by transforming growth factor-beta. K Horiguchi, T Shirakihara, A Nakano, T Imamura, K Miyazono, M Saitoh, J Biol Chem 2009 284 245 253 19010789
47. Small C-terminal domain phosphatase enhances snail activity through dephosphorylation. Y Wu, BM Evers, BP Zhou, J Biol Chem 2009 284 640 648 19004823
48. Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression. GM Jiang, HS Wang, F Zhang, KS Zhang, ZC Liu, R Fang, H Wang, SH Cai, J Du, Biochim Biophys Acta 1833 2013 663 671
49. Functional correlation between cell adhesive properties and some cell surface proteins. M Takeichi, J Cell Biol 1977 75 464 474 264120
50. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). G Berx, K Staes, J van Hengel, F Molemans, M Bussemakers, A von Bokhoven, F van Roy, Genomics 1995 26 281 289 7601454
51. The cell-cell adhesion molecule E-cadherin. F Van Roy, G Berx, Cell Mol Life Sci 2008 65 3756 3788 18726070
52. Roles of cadherins in patterning of the developing brain. M Takeichi, H Matsunami, T Inoue, Y Kimura, S Suzuki, T Tanaka, Dev Neurosci 1997 19 86 87 9078437
53. Identification of a putative cell adhesion domain of uvomorulin. D Vestweber, R Kemler, EMBO J 1985 4 3393 3398 2419126
54. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. A Cano, MA Perez-Moreno, I Rodrigo, A Locascio, MJ Blanco, MG del Barrio, F Portillo, MA Nieto, Nat Cell Biol 2000 2 76 83 10655586
55. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. L Larue, M Ohsugi, J Hirchenhain, R Kemler, Proc Natl Acad Sci U S A 1994 91 8263 8267 8058792
56. G9a interacts with snail and is critical for snail-mediated E-cadherin repression in human breast cancer. C Dong, Y Wu, J Yao, Y Wang, Y Yu, P Rychahou, B Evers, B Zhou, J Clin Investig 2012 122 1469 1486 22406531
57. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Z Hou, H Peng, K Ayyanathan, KP Yan, EM Langer, GD Longmore, FJ Rauscher III, Mol Cell Biol 2008 28 3198 3207 18347060
58. Dynamic regulation of histone lysine methylation by demethylases. Y Shi, JR Whetstine, Mol Cell 2007 25 1 14 17218267
59. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. H Peinado, E Ballestar, M Esteller, A Cano, Mol Cell Biol 2004 24 306 319 14673164
60. The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1. Y Lin, Y Wu, J Li, C Dong, X Ye, YI Chi, BM Evers, BP Zhou, EMBO J 2010 29 1803 1816 20389281
61. Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. C Dong, Y Wu, Y Wang, C Wang, T Kang, PG Rychahou, YI Chi, BM Evers, BP Zhou, Oncogene 2013 32 1351 1362 22562246
62. Suppression of Raf-1 kinase activity and MAP kinase signaling by RKIP. K Yeung, T Seitz, S Li, P Janosch, B McFerran, C Kaiser, F Fee, KD Katsanakis, DW Rose, H Mischak, JM Sedivy, W Kolch, Nature 1999 401 173 177 10490027
63. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. K Yeung, DW Rose, AS Dhillon, D Yaros, M Gusafsson, D Chatterjee, B McFerran, J Wyche, W Kolch, JM Sedivy, Mol Cell Biol 2001 21 7201 7217
64. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. D Chatterjee, Y Bai, Z Wang, S Beach, S Mott, R Roy, C Braastad, Y Sun, A Mukhopadhyay, BB Aggarwal, J Darnowski, P Pantazis, J Wyche, Z Fu, Y Kitagwa, ET Keller, JM Sedivy, KC Yeung, J Biol Chem 2004 279 17515 17523 14766752
65. RKIP downregulates B-Raf kinase activity in melanoma cancer cells. S Park, ML Yeung, S Beach, JM Shields, KC Yeung, Oncogene 2005 24 3535 3540 15782137
66. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. F Al-Mulla, S Hagan, AI Behbehani, MS Bitar, SS George, JJ Going, JJ Garcia, L Scott, N Fyfe, GI Murray, W Kolch, J Clin Oncol 2006 24 5672 5679 17179102
67. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Z Fu, Y Kitagawa, R Shen, R Shah, R Mehra, D Rhodes, PJ Keller, A Mizokami, R Dunn, AM Chinnaiyan, Z Yao, ET Keller, Prostate 2005 66 248 256
68. Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. S Beach, H Tang, S Park, AS Dhillon, ET Keller, W Kolch, KC Yeung, Oncogene 2008 27 2243 2248 17952120
69. Regulation of PTEN Function as a PIP3 Gatekeeper through Membrane. F Vazquez, P Devreotes, Cell Cycle 2006 5 1523 1527 16861931
70. Repression of PTEN Phosphatase by Snail1 Transcriptional Factor during Gamma Radiation-Induced Apoptosis. M Escriva, S Peiro, H Herranz, P Villagrasa, N Dave, B Montserrat-Sentis, SA Murray, C Franci, T Gridley, I Virtanen, A Garcia de herreros, Mol Cell Biol 2008 28 1528 1540 18172008
71. Regulation of PTEN transcription by p53. V Stambolic, D MacPherson, D Sas, Y Lin, B Snow, Y Jang, S Benchimol, TW Mak, Mol Cell 2001 8 317 325 11545734
72. Tumor suppressor PTEN: modulator of cell signalling, growth, migration and apoptosis. KM Yamada, M Araki, J Cell Sci 2002 114 2375 2382
73. Occludin: a novel integral membrane protein localizing at tight junctions. M Furuse, T Hirase, M Itoh, A Nagafuchi, S Yonemura, S Tsukita, S Tsukita, J Cell Biol 1993 123 1777 1788 8276896
74. Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues. Y Ando-Akatsuka, M Saitou, T Hirase, M Kishi, A Sakakibara, M Itoh, S Yonemura, M Furuse, S Tsukita, J Cell Biol 1996 133 43 47 8601611
75. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J Ikenouchi, M Matsuda, M Furuse, S Tsukita, J Cell Sci 2003 116 1959 1967 12668723
76. Regulation and roles for claudin-family tight junction proteins. M Findley, M Koval, IUBMB Life 2009 61 431 437 19319969
77. The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. O Martinez-Estrada, A Culleres, S Vilaro, Biochem J 2006 394 449 457 16232121
78. Loss of tight junction barrier function and its role in cancer metastasis. T Martin, W Jiang, BBA Biomembranes 2009 1788 872 891 19059202
79. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression. J Zaretsky, I Barnea, Y Aylon, M Gorivodsky, D Wreschner, I Keydar, Mol Cancer 2006 5 57 17083744
80. MUC1: a multifunctional cell surface component of reproductive tissue epithelia. M Brayman, A Thathiah, D Carson, Reprod Biol Endocrinol 2004 2 4 14711375
81. Mucins in cancer: protection and control of the cell surface. M Hollingsworth, B Swanson, Nat Rev Cancer 2004 4 45 60 14681689
82. Epithelial mucin genes. S Gendler, A Spicer, Annu Rev Physiol 1995 57 607 634 7778880
83. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. S Guaita, I Puig, C Franci, M Garrido, D Dominguez, E Batlle, E Sancho, S Dedhar, AG De Herreros, J Baulida, J Biol Chem 2002 277 39209 39216 12161443
84. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. E Sanchez-Tillo, A Lazaro, R Torrent, M Cuatrecasas, EC Vaquero, A Castells, P Engel, A Postigo, Oncogene 2010 29 3490 3500 20418909
85. Vimentin in cancer and its potential as a molecular target for cancer therapy. A Satelli, S Li, Cell Mol Life Sci 2011 68 3033 3046 21637948
86. Activation of the human vimentin gene by the Tax human T-cell leukemia virus. I. Mechanisms of regulation by the NF-kappa B transcription factor. A Lilienbaum, D Paulin, J Biol Chem 1993 268 2180 2188 8420985
87. TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members. Y Wu, X Zhang, M Salmon, X Lin, ZE Zehner, Biochim Biophys Acta 2007 1773 427 439 17270292
88. Vimentin is a novel AKT1 target mediating motility and invasion. QS Zhu, K Rosenblatt, KL Huang, G Lahat, R Brobey, S Bolshakov, T Nguyen, Z Ding, R Belousov, K Bill, X Luo, A Lazar, A Dicker, GB Mills, MC Hung, D Lev, Oncogene 2011 30 457 470 20856200
89. Transactivation of vimentin by beta-catenin in human breast cancer cells. C Gilles, M Polette, M Mestdagt, B Nawrocki-Raby, P Ruggeri, P Birembaut, JM Foidart, Cancer Res 2003 63 2658 2664 12750294
90. Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. SH Lang, C Hyde, IN Reid, IS Hitchcock, CA Hart, AA Bryden, JM Villette, MJ Stower, NJ Maitland, Prostate 2002 52 253 263 12210485
91. Vimentin affects the mobility and invasiveness of prostate cancer cells. Y Zhao, Q Yan, X Long, X Chen, Y Wang, Cell Biochem Funct 2008 26 571 577 18464297
92. Fibronectins: multifunctional modular glycoproteins. RO Hynes, KM Yamada, J Cell Biol 1982 95 369 377 6128348
93. DF Mosher, Fibronectin Academic Press, Inc., San Diego 1989
94. Fibronectin at a glance. R Pankov, K Yamada, J Cell Sci 2002 115 3861 3863 12244123
95. Evidence that binding to the carboxyl-terminal heparin-binding domain (HepII) dominates the interaction between plasma fibronectin and heparin. MJ Benecky, CG Kolvenback, DL Amrani, MN Mosesson, Biochem 1988 27 7565 7571
96. Interaction of heparin with fibronectin and isolated fibronectin domains. KC Ingham, SA Brew, DH Atha, Biochem J 1990 272 605 611 2268289
97. Identification of a novel heparin-binding site in the alternatively spliced IIICS region of fibronectin: roles of integrins and proteoglycans in cell adhesion to fibronectin splice variants. Z Mostafavi-Pour, JA Askari, JD Whittard, MJ Humphries, Matrix Biol 2001 20 63 73 11246004
98. The EIIIA segment of fibronectin is a ligand for integrins α9β1 andα 4β1 providing a novel mechanism for regulating cell adhesion by alternative splicing. YF Liao, PJ Gotwals, VE Koteliansky, D Sheppard, L Van De Water, J Biol Chem 2002 277 14467 14474 11839764
99. Structural analysis of collagen type I interactions with human fibronectin reveals a cooperative binding mode. MC Erat, B Sladek, ID Campbell, I Vakonakis, J Biol Chem 2013 288 17441 17450 23653354
100. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. EL George, EN Georges-Labouesse, RS Patel-King, H Rayburn, RO Hynes, Development 1993 119 1079 1091 8306876
101. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. R Moll, WW Franke, DL Schiller, B Geiger, R Krepler, Cell 1982 31 11 24 6186379
102. A structural scaffolding of intermediate filaments in health and disease. E Fuchs, DW Cleveland, Science 1998 279 514 519 9438837
103. 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. PA Coulombe, MB Omary, Curr Opin Cell Biol 2002 14 110 122 11792552
104. Keratins modulate hepatic cell adhesion, size and G1/S transition. L Galarneau, A Loranger, S Gilbert, N Marceau, Exp Cell Res 2007 313 179 194 17112511
105. Oncogenic regulation and function of keratins 8 and 18. RG Oshima, H Baribault, C Caulín, Cancer Metastasis Rev 1996 15 445 471 9034603
106. Functional role of matrix metalloproteinase 28 in the oral squamous cell carcinoma. MH Lin, SY Liu, HJ Su, YC Liu, Oral Oncol 2006 42 907 913 16730219
107. Matrix Metalloproteinases: a review. H Birkedal-Hansen, WG Moore, MK Bodden, LJ Windsor, B Birkedal-Hansen, A DeCarlo, JA Engler, Crit Rev Oral Biol Med 1993 4 197 250 8435466
108. Human 92- and 72- kilodalton type IV collagenases are elastases. RM Senior, GL Griffin, CJ Fliszar, SD Shapiro, GI Goldberg, HG Welgus, J Biol Chem 1991 266 7870 7875 1850424
109. Purification and properties of a gelatin-specific neutral protease from human skin. JL Seltzer, SA Adams, GA Grant, AZ Eisen, J Biol Chem 1981 256 4662 4668 6260809
110. Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (Gelatinase) derived from human skin. JL Seltzer, AZ Eisen, EA Bauer, NP Morris, RW Glanville, RE Burgeson, J Biol Chem 1989 264 3822 3826 2537292
111. Cleavage of collagen type X by human synovial collagenase and neutrophil elastase. SJ Gadher, TM Schmid, LW Heck, DE Woolley, Matrix 1989 9 109 115 2542740
112. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. P Huhtala, A Tuuttila, LT Chow, J Lohi, J Keski-Oja, K Tryggvason, J Biol Chem 1991 266 16485 16490 1653238
113. Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-β1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions. B Qiao, N Johnson, J Gao, Int J Oncol 2010 37 663 668 20664935
114. Metastatic potential correlates with enzymic degradation of basement membrane collagen. LA Liotta, K Tryggvason, S Garbisa, I Hart, CM Foltz, S Shafie, Nature 1980 284 67 68 6243750
115. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with C-Ha-ras but not C-Ha-ras plus Ad2-Ela. S Garbisa, R Pozzati, RJ Muschel, U Saffiotti, M Ballin, RH Goldfarb, G Khoury, LA Liotta, Cancer Res 1987 47 1523 1528 3028610
116. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. M Nakajima, DR Welch, PN Belloni, GL Nicholson, Cancer Res 1987 47 4869 4876 3621180
117. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. EJ Bernhard, RJ Muschel, EN Hughes, Cancer Res 1990 50 3872 3877 2162246
118. Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma. R Mahabir, M Tanino, A Elmansuri, L Wang, T Kimura, T Itoh, Y Ohba, H Nishihara, H Shirato, M Tsuda, S Tanaka, Neuro Oncol 2013 0 1 15
119. Induction of a β-catenin-LEF-1 complex by wnt-1 and transforming mutants of β-catenin. E Porfiri, B Rubinfeld, I Albert, K Hovanes, M Waterman, P Polakis, Oncogene 1997 15 2833 2839 9419974
120. Stabilization of β-catenin by genetic defects in melanoma cell lines. B Rubinfeld, P Robbins, M El-Gamil, I Albert, E Porfiri, P Polakis, Science 1997 275 1790 1792 9065403
121. Links between signal transduction, transcription and adhesion in epithelial bud development. C Jamora, R DasGupta, P Kocieniewski, E Fuchs, Nature 2003 422 317 322 12646922
122. Direct evidence for a role of betacatenin/LEF-1 signalling pathway in the induction of EMT. K Kim, Z Lu, ED Hay, Cell Biol Int 2002 26 463 476 12095232
123. Lymphoid enhancer factor/T cell factor expression in colorectal cancer. ML Waterman, Cancer Metastasis Rev 2004 23 41 52 15000148
124. Cooperation between Snail and LEF-1 transcription factors is essential for TGF-β1-induced epithelial-mesenchymal transition. D Medici, E Hay, D Goodenough, Mol Biol Cell 2006 17 1871 1879 16467384
125. Unraveling signaling cascades for the Snail family of transcription factors. B De Craene, F van Roy, G Berx, Cell Signal 2005 17 535 547 15683729
126. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience with long-term follow-up. CW Elston, IO Ellis, Histopathology 1991 19 403 410 1757079
127. Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients. M Dieterich, SN Goodman, RR Rojas-Corona, AB Emralino, D Jimenez-Joseph, ME Sherman, Acta Cytol 1994 38 945 952 7992584
128. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. MJ Blanco, G Moreno-Bueno, D Sarrio, A Locascio, A Cano, J Palacios, MA Nieto, Oncogene 2002 21 3241 3246 12082640
129. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. S Elloul, M Bukholt Elstrand, JM Nesland, CG Trope, G Kvalheim, I Goldberg, R Reich, B Davidson, Cancer 2005 103 1631 1643 15742334
130. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. W Jiao, K Miyazaki, Y Kitajima, Br J Cancer 2002 86 98 101 11857019
131. Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. A Miyoshi, Y Kitajima, K Miyazaki, Br J Cancer 2005 92 252 258 15668718
132. Clinicopathologic significance of the expression of Snail in hepatocellular carcinoma. HY Woo, AL Min, JY Choi, SH Bae, SK Yoon, CK Jung, Korean J Hepatol 2011 17 12 18 21494073
133. Expression of E-cadherin transcriptional regulators in ovarian carcinoma. S Elloul, I Silins, CG Trope, A Benshushan, B Davidson, R Reich, Virchows Arch 2006 449 520 528 17024425
134. Differential expression of the epithelial-mesenchymal transition regulators Snail, SIP1, and Twist in gastric cancer. E Rosiavitz, I Becker, K Specht, E Fricke, B Luber, R Busch, H Hofler, KF Becker, Am J Pathol 2002 161 1881 1891
135. Overexpression of Snail is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. NR Shin, EH Jeong, CI Choi, HJ Moon, CH Kwon, IS Chu, GH Kim, TY Jeon, DH Kim, JH Lee, Y Park do, BMC Cancer 2012 12 521 23151184
136. Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. K Yokoyama, N Kamata, E Hayashi, T Hoteiya, N Ueda, R Fujimoto, M Nagayama, Oral Oncol 2001 37 65 71 11120485
137. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. B Hotz, M Arndt, S Dullat, S Bhargava, HJ Buhr, HG Hotz, Clin Cancer Res 2007 13 4769 4776 17699854
138. Cancer statistics, 2009. A Jemal, R Siegel, E Ward, Y Hao, J Xu, MJ Thun, CA Cancer J Clin 2009 59 225 249 19474385
139. The transcriptional repressor SNAIL is overexpressed in human colon cancer. H Roy, T Smyrk, J Koetsier, T Victor, R Wali, Dig Dis Sci 2005 50 42 46 15712635
140. Overexpression of Snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. F Fan, S Samuel, KW Evans, J Lu, L Xia, Y Zhou, E Sceusi, F Tozzi, XC Ye, SA Mani, LM Ellis, Cancer Med 2012 1 5 16 23342249
141. Expression of transcription factors snail, slug, and twist in human bladder carcinoma. Q Yu, K Zhang, X Wang, X Liu, Z Zhang, J Exp Clin Cancer Res 2010 29 119 20809941
142. Snail expression is an independent predictor of tumor recurrence in superficial bladder cancers. F Bruyere, B Namdarian, NM Corcoran, J Pedersen, J Ockrim, BB Voelzke, U Mete, AJ Costello, CM Hovens, Urol Oncol 2010 28 591 596 19162513
143. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. I Poser, D Dominguez, A Garcia de Herreros, A Varnai, R Buettner, AK Bosserhoff, J Biol Chem 2001 276 24661 24666 11323412
144. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. C Kudo-Saito, H Shirako, T Takeuchi, Y Kawakami, Cancer Cell 2009 15 195 206 19249678
145. E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features. T Saito, Y Oda, M Tsuneyoshi, Am J Pathol 2001 159 2117 2124 11733362
146. Global cancer statistics. A Jemal, F Bray, MM Center, J Ferlay, E Ward, D Forman, CA Cancer J Clin 2011 61 69 90 21296855
147. Gleason grading: past, present and future. B Delahunt, RJ Miller, JR Srigley, AJ Evans, H Samaratunga, Histopathology 2012 60 75 86 22212079
148. Tumor suppressor gene E-cadherin and its role in normal and malignant cells. N Pecina-Slaus, Cancer Cell Int 2003 3 17 18 14613514
149. Proteoglycans in prostate cancer. IJ Edwards, Nat Rev Urol 2012 21 196 206
150. The role of Snail in prostate cancer. B Smith, V Odero-Marah, Cell Adh Migr 2012 6 433 441 23076049
151. Heparan sulfate proteoglycan expression in human lung-cancer cells. K Nackaerts, E Verbeken, G Deneffe, B Vanderschueren, M Demedts, G David, Int J Cancer 1997 74 335 345 9221815
152. Increased SNAIL expression and low syndecan levels are associated with high Gleason grade in prostate cancer. C Poblete, J Fulla, M Gallardo, V Munoz, EA Castellon, I Gallegos, HR Contreras, Int J Oncol 2014 44 647 654 24424718
153. The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway. Z Chen, S Li, K Huang, Q Zhang, J Wang, X Li, T Hu, S Wang, R Yang, Y Jia, H Sun, F Tang, H Zhou, J Shen, D Ma, S Wang, Hum Pathol 2013 44 2097 2105 23791009
154. Stem cells, cancer, and cancer stem cells. T Reya, SJ Morrison, MF Clarke, IL Weissman, Nature 2001 414 105 111 11689955
155. Prospective identification of tumorigenic breast cancer cells. M Al-Hajj, MS Wicha, A Benito-Hernandez, SJ Morrison, MF Clarke, Proc Natl Acad Sci U S A 2003 100 3983 3988 12629218
156. Cancer stem cells: are we missing the target? RJ Jones, WH Matsui, BD Smith, J Natl Cancer Inst 2004 96 583 585 15100335
157. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. K Takahashi, S Yamanaka, Cell 2006 126 663 676 16904174
158. Reprogramming fibroblasts into induced pluripotent stem cells with Bmi1. JH Moon, JS Heo, JS Kim, EK Jun, JH Lee, A Kim, J Kim, J Kim, KY Whang, YK Kang, S Yeo, HJ Lim, DW Han, DW Kim, S Oh, BS Yoon, HR Schöler, S You, Cell Res 2011 21 1305 1315 21709693
159. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. JH Moon, W Yun, J Kim, S Hyeon, PJ Kang, G Park, A Kim, S Oh, KY Whang, DW Kim, BS Yoon, S You, Biochem Biophys Res Commun 2013 431 444 449 23333380
160. Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3. L Zhu, H Qin, PY Li, SN Xu, HF Pang, HZ Zhao, DM Li, Q Zhao, J Exp Clin Cancer Res 2012 31 29 22458379
161. Expression of Notch-1 and its clinical significance in different histological subtypes of human lung adenocarcinoma. J Huang, H Song, B Liu, B Yu, R Wang, L Chen, J Exp Clin Cancer Res 2013 32 84 24423157
162. Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. R Fujii, Y Imanishi, K Shibata, N Sakai, K Sakamoto, S Shigetomi, N Habu, K Otsuka, Y Sato, Y Watanabe, H Ozawa, T Tomita, K Kameyama, M Fujii, K Ogawa, J Exp Clin Cancer Res 2014 33 40 24887090
163. Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway. W Zhuo, Y Wang, X Zhuo, Y Zhang, X Ao, Z Chen, Lung Cancer 2008 62 8 14 18372076
164. Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer. DS Hsu, HY Lan, CH Huang, SK Tai, SY Chang, TL Tsai, CC Chang, CH Tzeng, KJ Wu, JY Kao, MH Yang, Clin Cancer Res 2010 16 4561 4571 20823140
165. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. AM Haslehurst, M Koti, M Dharsee, P Nuin, K Evans, J Geraci, T Childs, J Chen, J Li, J Weberpals, S Davey, J Squire, PC Park, H Feilotter, BMC Cancer 2012 12 91 22429801
166. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. NK Kurrey, SP Jalgaonkar, AV Joglekar, AD Ghanate, PD Chaskar, RY Doiphode, SA Bapat, Stem Cells 2009 27 2059 2068 19544473
167. Expression of Snail in pancreatic cancer promotes metastasis and chemoresistance. T Yin, C Wang, T Liu, G Zhao, Y Zha, M Yang, J Surg Res 2007 141 196 203 17583745
168. Snail blocks the cell cycle and confers resistance to cell death. S Vega, AV Morales, OH Ocana, F Valdes, I Fabregat, MA Nieto, Genes Dev 2004 18 1131 1141 15155580
169. Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization. S Baritaki, K Yeung, M Palladino, J Berenson, B Bonavida, Cancer Res 2009 69 8376 8385 19843864
170. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis. AR Jazirehi, S Huerta-Yepez, G Cheng, B Bonavida, Cancer Res 2005 65 264 276 15665303
171. A potential mechanism of rituximab-induced inhibition of tumorgrowth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells. MI Vega, S Baritaki, S Huerta-Yepez, MA Martinez-Paniagua, B Bonavida, Leuk Lymphoma 2011 52 108 121 21133714
172. EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction. I Akalay, B Janji, M Hasmim, MZ Noman, JP Thiery, F Mami-Chouaib, S Chouaib, Autophagy 2013 9 1104 1106 23635487
173. Epithelial-to mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. I Akalay, B Janji, M Hasmim, MZ Noman, F André P De Cremoux, P Bertheau, C Badoual, P Vielh, AK Larsen, M Sabbah, TZ Tan, JH Keira, NT Hung, JP Thiery, F Mami-Chouaib, S Chouaib, Cancer Res 2013 73 2418 2427 23436798
174. p53, secreted by K-Ras-Snail pathway, is endocytosed by K-Ras-mutated cells; implication of target-specific drug delivery and early diagnostic marker. SH Lee, SJ Lee, JY Chung, YS Jung, SY Choi, SH Hwang, D Choi, NC Ha, BJ Park, Oncogene 2009 28 2005 2014 19347028
175. Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells. SH Lee, GN Shen, YS Jung, SJ Lee, JY Chung, HS Kim, Y Xu, Y Choi, JW Lee, NC Ha, GY Song, BJ Park, Oncogene 2010 29 4576 4587 20531295
176. Targeted inactivation of snail family EMT regulatory factors by a Co(III)-Ebox conjugate. A Harney, T Meade, C LaBonne, PLoS One 2012 7 32318 22393397
177. Dynamic chromatin modification sustains epithelial-mesenchymal transition following inducible expression of Snail-1. S Javaid, J Zhang, E Anderssen, JC Black, BS Wittner, K Tajima, DT Ting, GA Smolen, M Zubrowski, R Desai, S Maheswaran, S Ramaswamy, JR Whetstine, DA Haber, Cell Rep 2013 5 1679 1689 24360956
178. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin. P Shah, Y Gau, G Sabnis, Breast Cancer Res Treat 2014 143 99 111 24305977
179. Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers. G Hatzivassiliou, JF Haling, H Chen, K Song, S Price, R Heald, JF Hewitt, M Zak, A Peck, C Orr, M Merchant, KP Hoeflich, J Chan, SM Luoh, DJ Anderson, MJ Ludlam, C Wiesmann, M Ultsch, LS Friedman, S Malek, M Belvin, Nature 2013 501 232 236 23934108
180. MEK1/2 inhibitors in the treatment of gynecologic malignancies. C Miller, K Oliver, J Farley, Gynecol Oncol 2014 133 128 137 24434059
181. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. JA McCubrey, LS Steelman, WH Chappell, SL Abrams, RA Franklin, G Montalto, M Cervello, M Libra, S Candido, G Malaponte, MC Mazzarino, P Fagone, F Nicoletti, J Bäsecke, S Mijatovic, D Maksimovic-Ivanic, M Milella, A Tafuri, F Chiarini, C Evangelisti, L Cocco, AM Martelli, Oncotarget 2012 3 1068 1111 23085539
182. http://clinicaltrials.gov NIH Database.
183. Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 Å S Mimasu, T Sengoku, S Fukuzawa, T Umehara, S Yokoyama, Biochem Biophys Res Commun 2008 366 15 22 18039463
184. http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=444732&loc=ec-rcs Pubchem Database. []
185. http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4688&loc=ec-rcs Pubchem Database.
186. http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6918837 Pubchem Database.
187. http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4261 Pubchem Database.